World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Group
Safety and marketing issues raised about drugs generating large sales for pharmaceutical companies.
10/25/2006
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12.18.2013
Medical Journal Spikes Article On Industry Ties Of Kidney Group - WSJ.com
Wall Street Journal 12.26.2006
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04.10.2007
Suit Details How J&J Pushed Sales of Procrit
Wall Street Journal 05.10.2007
BusinessWeek 05.21.2007
Sequel for Vioxx Critic: Attack on Diabetes Pill
Wall Street Journal 05.22.2007
Avandia Concerns Reopen a Wider Debate
Wall Street Journal 05.23.2007
A Risk in Cholesterol Drugs Is Detected, but Is It Real?
Wall Street Journal 07.03.2007
Drug Makers to Curb Sales Of Medicine for Kids Under 2
Wall Street Journal 10.11.2007
Insulin Flop Costs Pfizer $2.8 Billion
Wall Street Journal 10.19.2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01.23.2008
How Heparin Maker in China Tackles Risks
Wall Street Journal 03.10.2008
Glaxo Becomes Master of Reinventing Drugs
Wall Street Journal 04.17.2008
Report Links Pfizer Drug To Accidents, Heart Trouble
Wall Street Journal 05.22.2008
BusinessWeek 06.26.2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07.10.2008
J&J Emails Raise Issues of Risperdal Promotion
Wall Street Journal 11.25.2008
Glaxo's Emails on Avandia Reveal Concern
Wall Street Journal 01.14.2009
AstraZeneca Papers Raise Seroquel Issues
Wall Street Journal 02.27.2009
New Drug for Diabetes Shows Few Heart Risks
Wall Street Journal 03.30.2009
Genentech Pulls Raptiva Psoriasis Drug
Wall Street Journal 04.09.2009
Some Doctors Question Safety Study on Glaxo's Avandia
Wall Street Journal 06.06.2009
New F.D.A. Chief Says She’ll Toughen Enforcement Efforts
New York Times 06.17.2009
Panel Recommends Ban on 2 Popular Painkillers
New York Times 07.01.2009
U.K. Issues Recall Of Various Generics
Wall Street Journal 07.03.2009
Drug Firms' Medical Staffs Say What Salespeople Can't
Wall Street Journal 06.26.2009
Document Details Plan to Promote Costly Drug
New York Times 09.02.2009
Drug Makers to Press for Guidance on Web Marketing
Wall Street Journal 11.12.2009
AstraZeneca Sharpens Focus on Drug Ethics
Wall Street Journal 12.23.2009
Using a Pfizer Grant, Courses Aim to Avoid Bias
New York Times 01.11.2010
Maker Plays Up Sexual Disorder, With a Pill in Waiting
New York Times 06.16.2010
Wall Street Journal 12.06.2010
Drug Reps Soften Their Sales Pitches
Wall Street Journal 01.10.2012
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10.25.2006
Wall Street Journal 05.08.2012
Cephalon Used Improper Tactics To Sell Drug, Probe Finds - WSJ.com
Wall Street Journal 11.21.2006
Marketing New Antismoking Pill Poses Challenges for Pfizer - WSJ.com
Wall Street Journal 11.22.2006
Pfizer to Cut 20% Of U.S. Sales Force, Signaling End of Era - WSJ.com
Wall Street Journal 11.29.2006
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07.20.2012
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03.12.2008
Stronger Warnings on 3 Drugs for Anemia
New York Times 11.09.2007
Lilly Said to Be Near $1.4 Billion U.S. Settlement
New York Times 01.15.2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
